Viewing nowRadova Tablet 40 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

MFDS item code 201907997 · Approved 2019.11.20 · Insurance code 647304190
Improvement of hyperlipidemia and prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it decreases the risk of myocardial infarction, stroke, vascular procedures, and angina in adults with multiple risk factors for coronary artery disease and in patients with type 2 diabetes. It also reduces the risk of fatal and non-fatal myocardial infarction and stroke, as well as hospitalization for congestive heart failure in patients who already have heart disease. It is used to treat hyperlipidemia, helping to lower cholesterol and triglyceride levels in patients with primary hypercholesterolemia and dyslipidemia, while also increasing good cholesterol (HDL). It is effective in certain dyslipidemia patients who do not respond to dietary changes. This drug is used for improving cardiovascular health and cholesterol regulation.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when an LDL cholesterol reduction of 45 % or more is required). This medicine is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering therapies (e.g., LDL apheresis), or if such lipid-lowering therapies are not possible. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
This drug may cause muscle-related symptoms, so if you experience muscle pain, weakness, or severe fatigue, consult a doctor immediately. This drug can affect liver function, so it should not be used if there are liver diseases or if liver function test results are abnormally high. Women who are pregnant, potentially pregnant, or breastfeeding should not take this medication. It should not be administered to children under 10 years old, certain patients with liver diseases, or anyone allergic to this drug or its components. Patients with a history of alcoholism or liver disease must use this drug with caution, and it is important to undergo liver function testing before administration. This drug may interact with other medications; therefore, inform your doctor or pharmacist about any other medications you are taking. Care should be taken when taking this medication alongside certain antibiotics, antifungals, antivirals, some antihypertensives, and antidiabetic agents. Regular blood tests are required to monitor liver function and muscle status during the use of this drug and report any unusual symptoms immediately. Additionally, appropriate contraception should be used during treatment, and if pregnancy is confirmed, discontinuation of the medication is necessary. Elderly patients or those with impaired kidney function should be monitored more carefully due to a higher risk of muscle abnormalities. There is no specific antidote in case of overdose, and treatment should be based on symptoms while continuously monitoring liver function and muscle enzyme levels. This medication should be kept out of reach of children and stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The appropriate storage temperature is between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.